Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elesclomol + Paclitaxel in Soft Tissue Sarcoma
NCT00087997Phase 2Completed
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of elesclomol in soft tissue sarcoma (STS), sponsored by Synta Pharmaceuticals Corp.. Started Jul 2004; status: completed.
02
Drugs
elesclomol
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00087997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087997.